This weekend is an off-reporting weekend, but we encourage our members to maintain a fluid understanding of the week-to-week market actions. With that being said we offer some light readings and charts to consider as we head into the coming trading week. It’s been a remarkable year in many ways, some more somber than others and as such we hope…
The Bulls Are Back In Town After a Brief Vacation
A financial market resource for the every-day investor and trader.
-
Fed Directed Price Action Drives Bearish Sentiment
Seth Golden, , Research Reports, 0
In roughly the last 10 trading sessions, the S&P 500 (SPX) and Nasdaq (COMPQ) have lost 10% of their...
-
Lead Biotech Analysts Updates Vaccine Forecast
Seth Golden, , Research Reports, 0
Pfizer has not yet accrued the32 COVID infections for its 1st interim analysis: The fact that Pfizer’s first interim...
-
Morgan Stanley: Sunday Start | What’s Next in Global Macro
Seth Golden, , Research Reports, 0
The Mid-Cycle Transition Over the past month, we’ve taken a different path than most equity strategists. Rather than getting...
-
Merrill Lynch: The Great New Dawn Era (2022 and beyond)
Seth Golden, , Research Reports, 0
Macro Strategy—No Respite For The Weary: After two years of a pandemic, the world now has to deal with...
-
Goldman Sachs: Why AI stocks aren’t in a bubble
Seth Golden, , Research Reports, 0
The explosion of interest in artificial intelligence this year has fueled a major rally in technology stocks, with a concentrated group...
-
Investors Wager Into The Eye of the Seasonal Storm
Seth Golden, , Research Reports, 0
Those who are unwilling to accept double-digit drawdowns are less likely to receive double-digit returns! Take your drawdown like...
-
Weekly Warm-up: Strong Earnings vs Mid Cycle De-Rating
Seth Golden, , Research Reports, 0
Following very strong 1H earnings, we raise our forecasts that leave us above consensus on 2021 but below on...
-
Macy’s Situation Is Getting Worse, As Previously Forecast: No Solution In Sight
Seth Golden, , Research Reports, 0
The situation at Macy’s (M) is as bad as it was when I began covering the company in January...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00